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Introduction
Magnesium sulphate (MS), causes bronchodilation by
inhibiting bronchial smooth muscle contraction, interferes
with parasympathetic stimulation, and prevents acetylcho-
line release to axon terminals [1]. It reduces inflammation
by inhibiting mast cell degranulation and reduces throm-
boxane, histamine and leukotrienes [2]. Some pediatric
studies suggest that MS, b-2-agonists and steroids are
beneficial in acute moderate/severe asthma by reducing
hospitalization and absolute risk [3].
Objectives
This paper 1) reviews the randomized controlled trials in
the literature on use of MS in asthma and 2) reports the
dramatic resolution of massive pulmonary atelectasis in an
asthmatic child within 2 hours of IV MS.
Case Report
A 5-year-old boy with past asthma presented with rapidly
progressing asthma unrelieved by prednisolone and
multiple doses of salbutamol, ipratropium bromide.
Examination revealed tachypnea, tachycardia, chest reces-
sion, tracheal tug, right tracheal deviation, dullness and
decreased breath sounds in right lower chest and wheez-
ing in other areas. Percutaneous Spo2 was 86% (room
air) and 95% with oxygen 5 L/minute. WBC 27.3 x
10^9/L, neutrophils 25.7 x 10^9/L, lymphocytes
1.1 x19^9/L. CRP was 11.6 (<10mg/L). Chest x-ray
confirmed atelectasis of right middle and lower lobes.
Antibiotics were started followed by IV methylpredni-
sone (1 mg/kg), aminophylline (10 mg/kg bolus), and
MS (50 mg/kg). Chest findings normalized within
2 hours. Spo2 improved to 95% on 2 L oxygen/minute.
Medication was discontinued save for salbutamol PRN,
oral prednisolone (1 mg/kg/day), and MDI fluticasone
50 mcg (BD). On day 2, the child was active and
playful. Chest examination and repeat chest x-ray were
normal.
Conclusion
Review of literature and dramatic resolution of asthma-
related massive atelectasis following intravenous MS in
our case establishes MS as an adjunct to standard ther-
apy in patients with severe, acute asthma including
atelectasis.
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